{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:32:20Z","timestamp":1792675940428,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2018\/18545-4"],"award-info":[{"award-number":["#2018\/18545-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/07725-1"],"award-info":[{"award-number":["2017\/07725-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2016\/00696-3"],"award-info":[{"award-number":["#2016\/00696-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2016\/15603-0"],"award-info":[{"award-number":["#2016\/15603-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["#2015\/21072-5"],"award-info":[{"award-number":["#2015\/21072-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#30395\/2021-0"],"award-info":[{"award-number":["#30395\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Subclinical atherosclerosis is frequently observed in type 1 diabetes\u00a0(T1D) although the mechanisms and markers involved in the evolution to established cardiovascular disease are not well known. High-density lipoprotein cholesterol in T1D is normal or even high, and changes in its functionality and proteomics are considered. Our aim was to evaluate the proteomics of HDL subfractions in T1D and control subjects and its association with clinical variables, subclinical atherosclerosis markers and HDL functionality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 50 individuals with T1D\u00a0and 30 matched controls were included. Carotid-femoral pulse wave velocity (PWV), flow-mediated vasodilation (FMD), cardiovascular autonomic neuropathy (CAN), and ten-year cardiovascular risk (ASCVDR) were determined. Proteomics (parallel reaction monitoring) was determined in isolated HDL<jats:sub>2<\/jats:sub> and HDL<jats:sub>3<\/jats:sub> that were also utilized to measure cholesterol efflux from macrophages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 45 quantified proteins, 13 in HDL<jats:sub>2<\/jats:sub> and 33 in HDL<jats:sub>3<\/jats:sub> were differentially expressed in T1D and control subjects. Six proteins related to lipid metabolism, one to inflammatory acute phase, one to complement system and one to antioxidant response were more abundant in HDL<jats:sub>2<\/jats:sub>, while 14 lipid metabolism, three acute-phase, three antioxidants and one transport in HDL<jats:sub>3<\/jats:sub> of T1D subjects. Three proteins (lipid metabolism, transport, and unknown function) were more abundant in HDL<jats:sub>2<\/jats:sub>; and ten (lipid metabolism, transport, protease inhibition), more abundant in HDL<jats:sub>3<\/jats:sub> of controls. Individuals with T1D had higher PWV and ten-year\u00a0ASCVDR, and lower FMD, Cholesterol efflux from macrophages was similar between T1D and controls. Proteins in HDL<jats:sub>2<\/jats:sub> and HDL<jats:sub>3<\/jats:sub>, especially related to lipid metabolism, correlated with PWV, CAN, cholesterol efflux, HDLc, hypertension, glycemic control, ten-year\u00a0ASCVDR, and statins use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HDL proteomics can be predictive of subclinical atherosclerosis in type 1 diabetes. Proteins that are not involved in reverse cholesterol transport may be associated with the protective role of HDL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-023-01007-y","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T02:02:30Z","timestamp":1678500150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case\u2013control study"],"prefix":"10.1186","volume":"15","author":[{"given":"Marcos Tadashi K.","family":"Toyoshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique F. M.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R. M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela B.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele P.","family":"Santos-Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa F. S.","family":"Goes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana A.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Caramelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella E.","family":"Ronsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Correa-Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"1007_CR1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care. 2021;44:S15-33. https:\/\/doi.org\/10.2337\/dc21-S002.","journal-title":"Diabetes Care"},{"key":"1007_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/nejmoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson A-M, Kosiborod M, Gudbj\u00f6rnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972\u201382. https:\/\/doi.org\/10.1056\/nejmoa1408214.","journal-title":"N Engl J Med"},{"key":"1007_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1932296814567227","volume":"9","author":"E Danese","year":"2015","unstructured":"Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol. 2015;9:169\u201376. https:\/\/doi.org\/10.1177\/1932296814567227.","journal-title":"J Diabetes Sci Technol"},{"key":"1007_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.diabet.2020.09.001","volume":"46","author":"B Verg\u00e8s","year":"2020","unstructured":"Verg\u00e8s B. Cardiovascular disease in type 1 diabetes: a review of epidemiological data and underlying mechanisms. Diabetes Metab. 2020;46:442\u20139. https:\/\/doi.org\/10.1016\/j.diabet.2020.09.001.","journal-title":"Diabetes Metab"},{"key":"1007_CR5","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1161\/CIRCULATIONAHA.104.529651","volume":"111","author":"P Libby","year":"2005","unstructured":"Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffher SM, et al. Report of the national heart, lung, and blood institute-national institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus. Circulation. 2005;111:3489\u201393. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.529651.","journal-title":"Circulation"},{"key":"1007_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2017.10.018","volume":"267","author":"S Ganjali","year":"2017","unstructured":"Ganjali S, Dallinga-Thie GM, Simental-Mend\u00eda LE, Banach M, Pirro M, Sahebkar A. HDL functionality in type 1 diabetes. Atherosclerosis. 2017;267:99\u2013109. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.018.","journal-title":"Atherosclerosis"},{"key":"1007_CR7","doi-asserted-by":"publisher","first-page":"164846","DOI":"10.1155\/2015\/164846","volume":"2015","author":"CT Chang","year":"2015","unstructured":"Chang CT, Yang CY, Tsai FJ, Lin SY, Chen CJ. Mass spectrometry-based proteomic study makes high-density lipoprotein a biomarker for atherosclerotic vascular disease. Biomed Res Int. 2015;2015:164846. https:\/\/doi.org\/10.1155\/2015\/164846.","journal-title":"Biomed Res Int"},{"key":"1007_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12944-017-0594-3","volume":"16","author":"M Femlak","year":"2017","unstructured":"Femlak M, Gluba-Brz\u00f3zka A, Cia\u0142kowska-Rysz A, Rysz J. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk. Lipids Health Dis. 2017;16:207. https:\/\/doi.org\/10.1186\/s12944-017-0594-3.","journal-title":"Lipids Health Dis"},{"key":"1007_CR9","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","volume":"143","author":"A Rohatgi","year":"2021","unstructured":"Rohatgi A, Westerterp M, von Eckardstein A, Remaley A, Rye K-A. HDL in the 21st century: a multifunctional roadmap for future HDL research. Circulation. 2021;143:2293\u2013309. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.044221.","journal-title":"Circulation"},{"key":"1007_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/MED.0000000000000705","volume":"29","author":"MJ Chapman","year":"2022","unstructured":"Chapman MJ. HDL functionality in type 1 and type 2 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes. 2022;29:112\u201323. https:\/\/doi.org\/10.1097\/MED.0000000000000705.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1007_CR11","unstructured":"The Davidson\/ Shah Lab: HDL Proteome Watch n.d. https:\/\/homepages.uc.edu\/~davidswm\/HDLproteome.html. Accessed 11 June 2021."},{"key":"1007_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14789450.2018.1402680","volume":"15","author":"B Shao","year":"2018","unstructured":"Shao B, Heinecke JW. Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions? Expert Rev Proteomics. 2018;15:31\u201340. https:\/\/doi.org\/10.1080\/14789450.2018.1402680.","journal-title":"Expert Rev Proteomics"},{"key":"1007_CR13","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.metabol.2016.06.008","volume":"65","author":"S Manjunatha","year":"2016","unstructured":"Manjunatha S, Distelmaier K, Dasari S, Carter RE, Kudva YC, Nair KS. Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus. Metabolism. 2016;65:1421\u201331. https:\/\/doi.org\/10.1016\/j.metabol.2016.06.008.","journal-title":"Metabolism"},{"key":"1007_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-019-0846-9","volume":"18","author":"E Gourgari","year":"2019","unstructured":"Gourgari E, Ma J, Playford MP, Mehta NN, Goldman R, Remaley AT, et al. Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study. Cardiovasc Diabetol. 2019;18:43. https:\/\/doi.org\/10.1186\/s12933-019-0846-9.","journal-title":"Cardiovasc Diabetol"},{"key":"1007_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/DMSO.S162008","volume":"11","author":"V do Nascimento de Oliveira","year":"2018","unstructured":"do Nascimento de Oliveira V, Lima-Neto ABM, van Tilburg MF, de Oliveira Monteiro-Moreira AC, Lobo MDP, Rondina D, et al. Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes. Diabetes, Metab Syndr Obes Targets Ther. 2018;11:289\u2013301. https:\/\/doi.org\/10.2147\/DMSO.S162008.","journal-title":"Diabetes, Metab Syndr Obes Targets Ther"},{"key":"1007_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman D, Egger M, Pocock S, G\u00f8tzsche P, Vandenbroucke J, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573\u20138.\u00a0https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010.","journal-title":"Ann Intern Med"},{"key":"1007_CR17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2013.280532.Comparison","volume":"310","author":"SS Martin","year":"2013","unstructured":"Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, et al. Comparison of a novel method vs the friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA J Am Med Assoc. 2013;310:2061\u20138. https:\/\/doi.org\/10.1001\/jama.2013.280532.Comparison.","journal-title":"JAMA J Am Med Assoc"},{"key":"1007_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"1007_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1164\/rccm.200703-500OC","volume":"176","author":"LF Drager","year":"2007","unstructured":"Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:706\u201312. https:\/\/doi.org\/10.1164\/rccm.200703-500OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1007_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","volume":"30","author":"LM Van Bortel","year":"2012","unstructured":"Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445\u20138. https:\/\/doi.org\/10.1097\/HJH.0b013e32834fa8b0.","journal-title":"J Hypertens"},{"key":"1007_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39:257\u201365. https:\/\/doi.org\/10.1016\/S0735-1097(01)01746-6.","journal-title":"J Am Coll Cardiol"},{"key":"1007_CR22","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285\u201393. https:\/\/doi.org\/10.2337\/dc10-1303.","journal-title":"Diabetes Care"},{"key":"1007_CR23","doi-asserted-by":"publisher","unstructured":"Admoni S. O polimorfismo de um \u00fanico nucleot\u00eddeo rs713041 no gene GPX4 modula a susceptibilidade \u00e0 neuropatia auton\u00f4mica cardiovascular em portadores de diabetes mellitus tipo 1 [PhD Thesis]. Universidade de S\u00e3o Paulo, 2017. https:\/\/doi.org\/10.11606\/T.5.2017.tde-25082017-075846.","DOI":"10.11606\/T.5.2017.tde-25082017-075846"},{"key":"1007_CR24","unstructured":"Steno Diabetes Center. Steno T1 Risk Engine n.d. https:\/\/steno.shinyapps.io\/T1RiskEngine\/. Accessed 20 Aug 2020."},{"key":"1007_CR25","unstructured":"ClinRisk. QRISK3 2018. https:\/\/qrisk.org\/three\/index.php. Accessed 3 Aug 2020."},{"key":"1007_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/0003-2697(75)90488-1","volume":"65","author":"TG Redgrave","year":"1975","unstructured":"Redgrave TG, Roberts DCK, West CE. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 1975;65:42\u20139. https:\/\/doi.org\/10.1016\/0003-2697(75)90488-1.","journal-title":"Anal Biochem"},{"key":"1007_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/acs.jproteome.9b00511","volume":"19","author":"ARM Silva","year":"2020","unstructured":"Silva ARM, Toyoshima MTK, Passarelli M, Di Mascio P, Ronsein GE. Comparing data-independent acquisition and parallel reaction monitoring in their abilities to differentiate high-density lipoprotein subclasses. J Proteome Res. 2020;19:248\u201359. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00511.","journal-title":"J Proteome Res"},{"key":"1007_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btq054.","journal-title":"Bioinformatics"},{"key":"1007_CR29","doi-asserted-by":"publisher","DOI":"10.25345\/C5MP1C","author":"MTK Toyoshima","year":"2021","unstructured":"Toyoshima MTK. Proteomics of high density lipoprotein subfractions in type 1 diabetes mellitus and controls. Mass Spectrom Interact Virtual Environ. 2021. https:\/\/doi.org\/10.25345\/C5MP1C.","journal-title":"Mass Spectrom Interact Virtual Environ"},{"key":"1007_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0022-1759(95)00136-X","volume":"184","author":"MD Englen","year":"1995","unstructured":"Englen MD, Valdez YE, Lehnert NM, Lehnert BE. Granulocyte\/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. J Immunol Methods. 1995;184:281\u20133. https:\/\/doi.org\/10.1016\/0022-1759(95)00136-X.","journal-title":"J Immunol Methods"},{"key":"1007_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.biocel.2005.09.016","volume":"38","author":"AP Machado","year":"2006","unstructured":"Machado AP, Pinto RS, Moys\u00e9s ZP, Nakandakare ER, Quint\u00e3o ECRR, Passarelli M. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. Int J Biochem Cell Biol. 2006;38:392\u2013403. https:\/\/doi.org\/10.1016\/j.biocel.2005.09.016.","journal-title":"Int J Biochem Cell Biol"},{"key":"1007_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2337\/diab.30.2.132","volume":"30","author":"RH Eckel","year":"1981","unstructured":"Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL. High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes. 1981;30:132\u20138. https:\/\/doi.org\/10.2337\/diab.30.2.132.","journal-title":"Diabetes"},{"key":"1007_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/XCE.0000000000000169","volume":"8","author":"A Jenkins","year":"2019","unstructured":"Jenkins A, Januszewski A, O\u2019Neal D. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovasc Endocrinol Metab. 2019;8:14\u201327. https:\/\/doi.org\/10.1097\/XCE.0000000000000169.","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"1007_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.atherosclerosis.2014.12.023","volume":"238","author":"SB Prenner","year":"2015","unstructured":"Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015;238:370\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.023.","journal-title":"Atherosclerosis"},{"key":"1007_CR35","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","volume":"27","author":"S Laurent","year":"2006","unstructured":"Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588\u2013605. https:\/\/doi.org\/10.1093\/eurheartj\/ehl254.","journal-title":"Eur Heart J"},{"key":"1007_CR36","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jdiacomp.2016.03.012","volume":"30","author":"S Terlemez","year":"2016","unstructured":"Terlemez S, Bulut Y, \u00dcn\u00fcvar T, Tokg\u00f6z Y, Eryilmaz U, \u00c7elik B. Evaluation of arterial stiffness in children with type 1 diabetes using the oscillometric method. J Diabetes Complications. 2016;30:864\u20137. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.03.012.","journal-title":"J Diabetes Complications"},{"key":"1007_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2337\/dc11-1475","volume":"35","author":"G Llaurad\u00f3","year":"2012","unstructured":"Llaurad\u00f3 G, Ceperuelo-Mallafr\u00e9 V, Vilardell C, Sim\u00f3 R, Freixenet N, Vendrell J, et al. Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation. Diabetes Care. 2012;35:1083\u20139. https:\/\/doi.org\/10.2337\/dc11-1475.","journal-title":"Diabetes Care"},{"key":"1007_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1479164118820641","volume":"16","author":"SN Admoni","year":"2019","unstructured":"Admoni SN, Santos-Bezerra DP, Perez RV, Patente TA, Monteiro MB, Cavaleiro AM, et al. Glutathione peroxidase 4 functional variant rs713041 modulates the risk for cardiovascular autonomic neuropathy in individuals with type 1 diabetes. Diabetes Vasc Dis Res. 2019;16:297\u20139. https:\/\/doi.org\/10.1177\/1479164118820641.","journal-title":"Diabetes Vasc Dis Res"},{"key":"1007_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.00591","volume":"12","author":"AI Vinik","year":"2018","unstructured":"Vinik AI, Casellini C, Parson HK, Colberg SR, Nevoret ML. Cardiac autonomic neuropathy in diabetes: a predictor of cardiometabolic events. Front Neurosci. 2018;12:1\u201311. https:\/\/doi.org\/10.3389\/fnins.2018.00591.","journal-title":"Front Neurosci"},{"key":"1007_CR40","doi-asserted-by":"publisher","first-page":"957901","DOI":"10.1155\/2011\/957901","volume":"2011","author":"S Liatis","year":"2011","unstructured":"Liatis S, Alexiadou K, Tsiakou A, Makrilakis K, Katsilambros N, Tentolouris N. Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res. 2011;2011:957901. https:\/\/doi.org\/10.1155\/2011\/957901.","journal-title":"Exp Diabetes Res"},{"key":"1007_CR41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/ATVBAHA.119.312556","volume":"39","author":"B Shao","year":"2019","unstructured":"Shao B, Zelnick LR, Wimberger J, Himmelfarb J, Brunzell J, Davidson WS, et al. Albuminuria, the high-density lipoprotein proteome, and coronary artery calcification in type 1 diabetes mellitus the DCCT\/EDIC study. Arterioscler Thromb Vasc Biol. 2019;39:1483\u201391. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312556.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1007_CR42","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3892\/mmr.2015.3930","volume":"12","author":"L Zhou","year":"2015","unstructured":"Zhou L, Li C, Gao L, Wang A. High-density lipoprotein synthesis and metabolism (Review). Mol Med Rep. 2015;12:4015\u201321. https:\/\/doi.org\/10.3892\/mmr.2015.3930.","journal-title":"Mol Med Rep"},{"key":"1007_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s005920170027","volume":"38","author":"CK Chang","year":"2001","unstructured":"Chang CK, Tso TK, Snook JT, Huang YS, Lozano RA, Zipf WB. Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose. Acta Diabetol. 2001;38:37\u201342. https:\/\/doi.org\/10.1007\/s005920170027.","journal-title":"Acta Diabetol"},{"key":"1007_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-511X-12-15","volume":"12","author":"ACR Feitosa","year":"2013","unstructured":"Feitosa ACR, Feitosa-Filho GS, Freitas FR, Wajchenberg BL, Maranh\u00e3o RC. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. Lipids Health Dis. 2013;12:15. https:\/\/doi.org\/10.1186\/1476-511X-12-15.","journal-title":"Lipids Health Dis"},{"key":"1007_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2018.11.020","volume":"280","author":"D Bojanin","year":"2019","unstructured":"Bojanin D, Vekic J, Milenkovic T, Vukovic R, Zeljkovic A, Stefanovic A, et al. Association between proprotein convertase subtilisin\/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: effects of glycemic control. Atherosclerosis. 2019;280:14\u201320.\u00a0https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.11.020.","journal-title":"Atherosclerosis"},{"key":"1007_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00395-015-0463-z","volume":"110","author":"R Schulz","year":"2015","unstructured":"Schulz R, Schluter K, Laufs U. Molecular and cellular function of the proprotein convertase subtilisin\/kexin type 9 (PCSK9). Basic Res Cardiol. 2015;110:4. https:\/\/doi.org\/10.1007\/s00395-015-0463-z.","journal-title":"Basic Res Cardiol"},{"key":"1007_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1194\/jlr.M059089","volume":"56","author":"T Vaisar","year":"2015","unstructured":"Vaisar T, Tang C, Babenko I, Hutchins P, Wimberger J, Suffredini AF, et al. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res. 2015;56:1519\u201330. https:\/\/doi.org\/10.1194\/jlr.M059089.","journal-title":"J Lipid Res"},{"key":"1007_CR48","doi-asserted-by":"publisher","first-page":"e0115320","DOI":"10.1371\/journal.pone.0115320","volume":"10","author":"HN Yassine","year":"2015","unstructured":"Yassine HN, Trenchevska O, He H, Borges CR, Nedelkov D, Mack W, et al. Serum amyloid A truncations in type 2 diabetes mellitus. PLoS ONE. 2015;10:e0115320. https:\/\/doi.org\/10.1371\/journal.pone.0115320.","journal-title":"PLoS ONE"},{"key":"1007_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2337\/dc19-0772","volume":"43","author":"T Vaisar","year":"2020","unstructured":"Vaisar T, Kanter JE, Wimberger J, Irwin AD, Gauthier J, Wolfson E, et al. High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes. Diabetes Care. 2020;43:178\u201386. https:\/\/doi.org\/10.2337\/dc19-0772.","journal-title":"Diabetes Care"},{"key":"1007_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1067\/mva.2001.116301","volume":"34","author":"N Sivamurthy","year":"2001","unstructured":"Sivamurthy N, Stone DH, LoGerfo FW, Quist WC. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells. J Vasc Surg. 2001;34:716\u201323. https:\/\/doi.org\/10.1067\/mva.2001.116301.","journal-title":"J Vasc Surg"},{"key":"1007_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01591-9","volume":"21","author":"D Denimal","year":"2022","unstructured":"Denimal D, Monier S, Simoneau I, Duvillard L, Verg\u00e8s B, Bouillet B. HDL functionality in type 1 diabetes\u202f: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control. Cardiovasc Diabetol. 2022;21:1\u20139. https:\/\/doi.org\/10.1186\/s12933-022-01591-9.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01007-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-023-01007-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01007-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T02:02:36Z","timestamp":1678500156000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-023-01007-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1186\/s13098-023-01007-y","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,11]]},"assertion":[{"value":"14 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants signed an informed written consent form previously approved by The Ethical Committee for Human Research Protocols of the Hospital das Clinicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo (#3.796.622; 01\/09\/2020), in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no conflicts of interest. All authors have read and approved the submission of the manuscript; the manuscript has not been published and is not being considered for publication elsewhere, in whole or in part, in any language.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}